New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has reduced prices of 43 commonly used essential medicines by up to 35%. These drugs are used in treatment of ailments like diabetes, cancer, asthma, cardiovascular diseases, mental disorders and kidney failure.
While some new drugs have been brought under price control, the prices of around 30 drugs, which were already under price control, have been further slashed. The regulator has also allowed a slight increase in prices of two medicines based on review order issued by the pharmaceuticals department.
“The reduction is in the range of 5-35%,” according to a senior official. The NPPA issued the order late Friday evening notifying the new price ceilings. Since March, NPPA has fixed prices of 540 essential medicines resulting in an effective saving of around Rs 3,000 crore, reports ToI.